PHARMACOGENETICS OF REPRODUCTIVE MEDICINE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AFSHARIAN P.; SHIVA M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Fertility & Sterility Year:2013 | Volume:7 | Issue:SUPPLEMENT 1 Page(s): 23-23

Download Full-Text

View:

270

Download:

Cites:

Information Journal Paper

Title

PHARMACOGENETICS OF REPRODUCTIVE MEDICINE

Author(s)

AFSHARIAN P. | SHIVA M.

Keywords

Not Registered.

Abstract

Adverse drug reactions (ADRs) are a major problem in drug therapy and drug development. Inter-individual genetic differences can have significant roles in determining an individual's susceptibility to ADRs. The rapid development of techniques in the area of genome analysis has put the scientific community in a power position and facilitated identification of new pharmacogenomic biomarkers that can provide predictive tools for improved drug response and fewer ADRs. Such biomarkers mainly originate from genes encoding drug-metabolizing enzymes, drug transporters, drug targets and human leukocyte antigens.Understanding pharmacogenetic (PG) differences in drug response and tolerability has been an important area of research in personalized medicine, but the clinical utility of PGs testing has not been established very well. Identification of genetic polymorphisms due to single nucleotide polymorphisms is the most common approach. PG studies are committed to selecting the best therapy for every patient with a minimum risk of complications. Furthermore, these studies allow the development of clinical tests based on the presence of profiles of biomolecules and other biological markers useful for routine diagnosis.Since genetic variations play an important role in reproductive medicine, pharmacogenetics studies open a new field to modify and develop the treatments of infertile couples. For instance, the application of PG to assisted reproductive techniques (ART) will help clinicians to improve the efficacy of hormone treatments that are being routinely applied during ART protocols. As an example, FSH- and estrogen-receptors are genetic markers involving controlled ovarian hyperstimulation as clinical studies have demonstrated that the p.N680S polymorphism of the FSH-receptor gene determines the less ovarian response to FSH stimulation in patients undergoing IVF. Consequently, pharmacogenetics can assist physicians with prescribing medicine to achieve the controlled ovarian stimulation.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

AFSHARIAN, P., & SHIVA, M.. (2013). PHARMACOGENETICS OF REPRODUCTIVE MEDICINE. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, 7(SUPPLEMENT 1), 23-23. SID. https://sid.ir/paper/305517/en

Vancouver: Copy

AFSHARIAN P., SHIVA M.. PHARMACOGENETICS OF REPRODUCTIVE MEDICINE. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY[Internet]. 2013;7(SUPPLEMENT 1):23-23. Available from: https://sid.ir/paper/305517/en

IEEE: Copy

P. AFSHARIAN, and M. SHIVA, “PHARMACOGENETICS OF REPRODUCTIVE MEDICINE,” INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, vol. 7, no. SUPPLEMENT 1, pp. 23–23, 2013, [Online]. Available: https://sid.ir/paper/305517/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops